Results 101 to 110 of about 17,802 (177)
Necrotizing fungal osteomyelitis and fingolimod, 4 years after treatment with fingolimod
Fingolimod has been the first approved oral medication in MS for its relapsing remitting type. It is a non-selective sphingosine1-phosphate (S1P) receptor modulator on lymphocytes. Engagement of this receptor blocks the T cells and B cells migration from
Harirchian, M.H. +4 more
core
Objective: The purpose of this study was to investigate the effects of Crocin on brain neuroterophins, cognition, sensory and motor dysfunction and compare to fingolimod effects in toxic-induced demyelination with Ethidium Bromide (EB) in female Wistar ...
Rouholah Fatemi +3 more
doaj +1 more source
An expansion in the availability of generic specialty disease modifying therapies (DMTs) for treatment of multiple sclerosis (MS) has increased recently.
Darin T. Okuda +7 more
doaj +1 more source
Therapeutic Potential of Fingolimod in Diabetes Mellitus and Its Chronic Complications
Jie Li,1,2 Xinyu Nan,1 Yixuan Ma,3 Zhen Wang,4 Hui Fang1,2 1Department of Internal Medicine, Hebei Medical University, Shijiazhuang, 050000, People’s Republic of China; 2Department of Endocrinology, Tangshan Gongren Hospital, Tangshan, 063000, People’s ...
Fang H, Li J, Ma Y, Nan X, Wang Z
core
Background A sepsis-like syndrome is known to occur after cardiac arrest, leading to cerebral infiltration by white blood cells (WBC). We hypothesized that pharmacological sequestration of WBC, and more specifically lymphocytes within lymphoid tissues ...
Yara Abi Zeid Daou +11 more
doaj +1 more source
Three cases of non-carryover fingolimod-PML
\(\bf Objective\) To report the course of 3 recent Japanese and European cases of fingolimod-associated progressive multifocal leukoencephalopathy (PML) and to analyze its risk factors and increased incidence in Japan.
Nakahara, Jin (PhD) +9 more
core +1 more source
Phosphoproteomic dysregulation promotes tumor proliferation in Cushing's disease. [PDF]
Asuzu DT +20 more
europepmc +1 more source
Combined Modulation of Ceramide and S1P Pathways Induces Strong Cytotoxicity in SH-SY5Y Neuroblastoma Cells. [PDF]
Cakir CO, Sezer CV, Cengiz M, Kutlu HM.
europepmc +1 more source
Fungal Infections Associated with Sphingosine 1-Phosphate Receptor Modulators: Immunological Mechanisms, Clinical Patterns, and Management Considerations. [PDF]
Yazdan KM, Madam ST, Pasula S.
europepmc +1 more source
Association of HALP score with clinical and radiological activity following fingolimod discontinuation in patients with multiple sclerosis. [PDF]
Gokce SF, Bolayir A, Demir E, Cigdem B.
europepmc +1 more source

